GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1004 participants.
Also called NCT05693545
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 1,004 participants
- Registry
-
NCT05693545
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Uganda
- Registry status
- Completed
Technical summary
Registry record NCT05693545. Randomized; single masking; primary purpose treatment. Start 2023-09-01 (actual); primary completion 2026-10-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial
- Condition
- Rheumatic Heart Disease
- Intervention (Drug)
- phenoxymethyl penicillin
- Intervention (Drug)
- intramuscular benzathine penicillin G (BPG) prophylaxis
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Collaborator
- Uganda Heart Institute
Record details
- Record id
cardio:ct-nct05693545- Content hash
b4cc6c728d17ee37d7dad350a2fa84bbd63cb39bb3fd32ce01307c7394d8cd4e